Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(20%)
Results Posted
20%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
4
40%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(5)
Terminated(2)
Other(1)

Detailed Status

Completed5
Recruiting2
unknown1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (20.0%)
N/A4 (80.0%)

Trials by Status

recruiting220%
completed550%
unknown110%
withdrawn110%
terminated110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
PROCEDURE
Total Trials
10